asthma
exacerb
associ
viral
respiratori
tract
infect
rti
yet
influenc
viral
pathogen
divers
asthma
outcom
poorli
understood
limit
scope
throughput
convent
viral
detect
method
method
investig
capabl
virochip
dna
microarraybas
viral
detect
platform
character
viral
divers
rti
adult
without
asthma
result
virochip
detect
virus
higher
proport
sampl
cultur
isol
exhibit
high
concord
compar
sensit
specif
pathogenspecif
polymeras
chain
reaction
similar
spectrum
virus
identifi
rti
patient
subgroup
howev
unexpect
divers
among
human
coronavirus
hcov
human
rhinovirus
hrv
reveal
one
hcov
correspond
newli
recogn
virus
differ
serotyp
hrv
detect
includ
set
diverg
isol
form
distinct
genet
subgroup
conclus
virochip
detect
known
novel
variant
viral
pathogen
present
rti
given
divers
detect
largerscal
studi
necessari
determin
whether
particular
substrain
virus
confer
elev
risk
asthma
exacerb
asthma
exacerb
associ
viral
respiratori
tract
infect
rti
young
children
varieti
viral
pathogen
accompani
wheez
episod
notabl
respira
tori
syncyti
viru
rsv
review
older
children
adult
human
rhinovirus
hrv
implic
major
case
variabl
contribut
human
coronavirus
hcov
influenza
virus
parainfluenza
virus
rsv
human
metapneumoviru
hmpv
review
howev
factor
determin
clinic
outcom
associ
rti
person
asthma
well
understood
host
factor
govern
inflammatori
immun
respons
demonstr
influenc
whether
host
asthma
experienc
viral
rti
develop
exacerb
symptom
contrast
remain
unresolv
whether
variat
viral
pathogen
may
also
influenc
outcom
exampl
despit
promin
associ
hrv
asthma
exacerb
deliber
inocul
laboratoryadapt
isol
subject
asthma
produc
wheez
despit
effici
infect
gener
upper
respiratori
tract
symptom
although
experiment
hrv
inocul
studi
demonstr
clinic
signific
exacerb
small
declin
pulmonari
function
observ
likewis
everi
cold
subject
asthma
associ
exacerb
asthma
symptom
find
rais
possibl
respiratori
viral
pathogen
may
greater
potenti
other
trigger
asthma
exacerb
suscept
host
spectrum
viral
isol
recov
rti
person
asthma
experi
exacerb
differ
person
asthma
whose
rti
trigger
exacerb
prior
studi
attempt
make
comparison
gener
use
method
differenti
among
differ
subtyp
virus
within
famili
estim
number
hrv
isol
rather
identifi
serotyp
genotyp
may
insuffici
given
certain
isol
hrv
demonstr
ineffici
trigger
asthma
inocul
part
reason
pauciti
prior
studi
type
deriv
limit
convent
viral
detect
method
viral
cultur
insensit
antigen
test
reason
sensit
unavail
sever
import
class
pathogen
notabl
hrv
hcov
design
discrimin
among
isol
given
viral
speci
polymeras
chain
reaction
pcr
method
high
sensit
limit
detect
previous
character
highli
conserv
viral
sequenc
develop
altern
comprehens
strategi
viral
detect
use
virochip
dna
microarray
bear
conserv
sequenc
known
virus
human
anim
plant
microb
addit
abil
virochip
detect
known
virus
also
detect
new
member
known
viru
famili
crosshybridizationa
signific
advantag
pcrbase
method
appli
virochip
ongo
prospect
studi
design
analyz
divers
virus
caus
rti
adult
without
asthma
particular
attent
given
provok
asthma
attack
recruit
adult
without
asthma
advertis
commun
web
site
craigslist
http
sfbaycraigslistorg
post
flyer
campu
send
email
messag
subject
respond
previou
advertis
research
studi
particip
recruit
start
fall
extend
end
decemb
announc
request
subject
contact
us
within
h
onset
cold
symptom
evalu
subject
first
within
day
cold
onset
visit
day
cold
symptom
visit
week
longer
thereaft
assess
baselin
statu
visit
eightythre
subject
enrol
asthma
asthma
defin
histori
asthma
symptom
recurr
dyspnea
wheez
chest
tight
associ
posit
methacholin
test
result
subject
without
asthma
neither
histori
asthma
symptom
posit
methacholin
test
result
inform
purpos
procedur
risk
particip
sign
informedcons
form
approv
univers
california
san
francisco
committe
human
research
studi
procedur
first
visit
particip
complet
questionnair
demograph
medic
histori
asthma
histori
date
onset
cold
symptom
visit
particip
provid
inform
sever
current
upper
lower
respiratori
tract
symptom
use
valid
cold
questionnair
diari
form
describ
elsewher
spirometri
measur
forc
expir
volum
fev
forc
vital
capac
fvc
obtain
percentag
predict
calcul
use
crapo
equat
nasal
lavag
nl
perform
instil
ml
warm
normal
salin
nostril
dwell
time
subject
expel
nasal
content
plastic
cup
subject
asthma
record
symptom
sever
pm
peak
flow
measur
airwatch
imetriku
diari
twice
daili
day
visit
day
visit
visit
procedur
repeat
day
baselin
week
longer
onset
cold
symptom
definit
asthma
exacerb
initi
studi
defin
asthma
exacerb
either
worsen
asthma
symptom
requir
corticosteroid
system
topic
worsen
symptom
basi
studi
measur
latter
defin
increas
daili
asthma
symptom
score
point
rang
point
baselin
daili
averag
least
day
togeth
least
follow
decreas
fev
first
visit
decreas
peak
flow
measur
least
day
cold
week
increas
daili
albuterol
use
puff
least
day
cold
week
specimen
process
nl
specimen
visit
day
onset
cold
symptom
analyz
presenc
viru
pcr
viral
cultur
virochip
microarray
analysi
microarray
analysi
pcr
ml
homogen
nl
specimen
mix
ml
rlt
buffer
qiagen
contain
frozen
bedsid
dri
ice
store
nl
aliquot
cultur
duplic
combin
differ
cell
line
hela
primari
monkey
kidney
hfdl
inhous
line
human
fetal
diploid
lung
cell
california
depart
health
servic
viral
rickettsi
diseas
laboratori
richmond
specimen
inocul
cell
type
cultur
least
includ
primari
monkey
kidney
human
fetal
diploid
cytopath
effect
occur
viral
antigen
detect
test
respiratori
viral
antigen
detect
kit
chemicon
perform
identifi
antigen
adenoviru
rsv
influenza
virus
b
parainfluenza
virus
enterovirus
rhinovirus
differenti
reactiv
monoclon
panenteroviru
reagent
chemicon
enteroviru
monoclon
antibodi
dako
cytom
enteroviru
clone
rna
extract
sampl
mask
total
rna
extract
oncolumn
recombin
dnase
treatment
step
use
rneasi
miniprep
kit
qiagen
accord
manufactur
instruct
amplif
microarray
analysi
rna
randomli
amplifi
label
hybrid
virochip
microarray
describ
elsewher
protocol
wang
et
al
microarray
scan
use
axon
scanner
genepix
softwar
version
axon
instrument
ak
blind
viral
cultur
isol
hrv
pcr
result
interpret
hybrid
signatur
epredict
comput
tool
develop
virochip
array
hybrid
signatur
use
determin
virochip
result
p
valu
cutoff
posit
set
describ
elsewher
sampl
multipl
virus
met
threshold
evalu
hierarch
cluster
analysi
sumnorm
backgroundsubtract
array
hybrid
intens
nl
specimen
use
cluster
softwar
version
cooccurr
sampl
within
cluster
use
make
call
specimen
either
multipl
signific
epredict
score
signific
epredict
score
viralposit
call
confirm
recoveri
viral
sequenc
specif
pcr
hrv
detect
sampl
ml
randomli
amplifi
materi
use
independ
pcr
detect
sequenc
hrv
capsid
gene
junction
describ
elsewher
pcr
perform
blind
manner
primer
posit
nation
center
biotechnolog
inform
ncbi
access
number
posit
use
pcr
cycl
compar
sequenc
analysi
recov
hrv
pcr
product
clustalw
version
use
align
capsid
gene
junction
sequenc
obtain
clinic
isol
hrv
refer
hrv
serotyp
neighborjoin
phylogenet
tree
gener
result
align
use
phylip
packag
version
specif
pcr
hcov
hcovposit
sampl
identifi
virochip
microarray
analysi
ml
randomli
amplifi
materi
use
pcr
detect
region
polymeras
gene
use
pancov
primer
describ
elsewher
amplif
cycl
sequenc
analysi
hcov
pcr
product
amplifi
clinic
isol
pcr
product
extract
use
qiaquick
qiagen
either
sequenc
directli
use
pathogenspecif
primer
subclon
topo
vector
invitrogen
sequenc
use
forward
revers
primer
bigdy
cycl
sequenc
kit
abi
autom
sequenc
appli
biosystem
ident
hcov
present
studi
infer
basi
highest
score
match
blast
analysi
version
result
sequenc
amplifi
cdna
subclon
topo
plasmid
invitrogen
three
hundr
eightyfour
coloni
pick
dna
purifi
magnet
bead
isol
follow
dna
sequenc
use
bigdy
cycl
sequenc
kitabi
sequenc
sequenc
read
assembl
use
cons
linux
version
assembl
screen
blast
analysi
remov
contig
human
bacteri
sequenc
similar
gap
assembl
fill
synthesi
oligonucleotid
least
bp
overlap
sequenc
avail
contig
access
number
genbank
access
number
sequenc
virus
present
geo
databas
http
wwwncbinlmnihgovgeo
seri
access
number
virochip
microarray
data
present
first
goal
analysi
assess
perform
virochip
rel
convent
viral
detect
method
use
set
nl
specimen
ongo
prospect
studi
natur
acquir
upper
rti
naturi
adult
without
asthma
total
cold
event
captur
studi
avail
anal
ysi
breakdown
particip
specimen
associ
clinic
outcom
correspond
virochip
result
summar
figur
naturi
specimen
analyz
independ
blind
manner
distinct
viral
detect
method
virochip
analysi
cultur
isol
common
respiratori
pathogen
hrv
rsv
influenza
virus
b
human
parainfluenza
virus
adenoviru
human
enteroviru
pcr
hrv
virochip
detect
virus
followup
pcr
sequenc
recoveri
perform
confirm
presenc
detect
viral
speci
high
proport
specimen
test
posit
viru
virochip
analysi
reflect
outpati
set
studi
preval
viru
famili
detect
virochip
correspond
hrv
hcov
figur
tabl
four
addit
virus
gener
thought
associ
lower
rtisrsv
close
relat
hmpv
influenza
viru
human
parainfluenza
viruswer
also
detect
also
detect
doubl
infect
rsv
plu
hcov
rsv
plu
influenza
viru
figur
tabl
contrast
viru
detect
cultur
isol
sampl
three
differ
viral
pathogen
hrv
rsv
influenza
viru
doubl
infect
detect
method
tabl
headtohead
comparison
assay
yield
overal
low
concord
virtual
discord
result
correspond
result
posit
virochip
neg
cultur
isol
result
surpris
given
known
limit
viral
cultur
isol
also
compar
perform
virochip
pathogenspecif
pcr
known
high
sensit
address
statist
signific
manner
focus
pcr
detect
hrv
common
pathogen
detect
studi
popul
found
excel
concord
agreement
virochip
hrvspecif
pcr
result
indic
virochip
analysi
highli
sensit
specif
viral
detect
method
comparison
pathogenspecif
pcr
tabl
analysi
virochip
hybrid
signatur
hcov
detect
among
studi
subject
reveal
distinct
signatur
figur
pcr
recoveri
sequenc
analysi
fragment
hcov
polymeras
gene
reveal
signatur
correspond
distinct
hcov
subtyp
isol
share
sequenc
ident
correspond
hcov
polymeras
gene
sequenc
present
ncbi
databas
surprisingli
bulk
hcov
detect
outpati
popul
correspond
common
hcov
type
histor
detect
us
adult
rti
hcov
detect
studi
popul
differ
hcov
type
detect
sampl
collect
differ
time
studi
isol
detect
person
cold
occur
earli
winter
wherea
isol
detect
late
fall
isol
earli
winter
isol
sole
isol
identifi
midfal
hcov
infect
detect
studi
popul
interestingli
detect
person
asthma
infect
accompani
exacerb
asthma
symptom
commonli
detect
viru
studi
popul
hrv
figur
tabl
investig
hrv
divers
sequenc
junction
capsid
gene
hrv
isol
perform
phylogenet
analysi
sequenc
publish
sequenc
hrv
serotyp
refer
strain
found
virochip
hybrid
signatur
observ
correspond
differ
hrv
hrva
serotyp
hrvb
serotyp
novel
third
set
diverg
hrv
refer
hrv
x
figur
possess
slightli
sequenc
similar
hrva
hrvb
refer
serotyp
none
diverg
hrv
x
isol
cultur
thu
unambigu
detect
classif
isol
convent
serotyp
drug
suscept
receptortyp
usag
assay
possibl
recoveri
complet
code
sequenc
hrv
x
isol
hrv
hrv
analysi
sequenc
ident
repres
subset
fulli
sequenc
hrva
subgroup
genom
fulli
sequenc
hrvb
subgroup
genom
indic
hrv
x
isol
inde
hrv
scan
pairwis
ident
reveal
differ
hrv
x
hrva
subgroup
genom
confin
singl
locu
span
entir
genom
figur
although
phylogenet
analysi
indic
hrv
x
isol
similar
hrva
hrvb
refer
serotyp
strain
comparison
level
genomewid
sequenc
ident
share
within
fulli
sequenc
subset
hrva
genom
level
sequenc
ident
share
hrva
hrv
x
isol
show
hrv
x
isol
almost
genet
distinct
hrva
hrvb
subgroup
genom
figur
moreov
pairwis
sequenc
ident
hrv
x
genom
much
lower
detect
among
fulli
sequenc
hrva
hrvb
subgroup
genom
data
shown
taken
togeth
data
demonstr
hrv
x
isol
correspond
novel
diverg
subgroup
hrv
suggest
diverg
branch
hrv
x
isol
may
possess
higher
level
genet
divers
seen
previous
hrva
hrvb
subgroup
first
prospect
studi
use
panvir
detect
strategi
investig
influenc
viral
pathogen
clinic
outcom
rti
person
asthma
find
like
pcr
virochip
technolog
superior
standard
cultur
isol
method
detect
viral
pathogen
moreov
virochip
exhibit
compar
sensit
specif
pathogenspecif
pcr
whole
distribut
proport
distinct
viral
pathogen
detect
virochip
agre
previou
pcrbase
analys
viral
pathogen
associ
upper
rti
accompani
exacerb
asthma
symptom
howev
virochip
analysi
allow
us
uncov
remark
amount
divers
among
viral
pathogen
rel
small
studi
popul
divers
indic
futur
studi
seek
link
particular
viru
set
virus
discret
clinic
outcom
exacerb
asthma
symptom
need
includ
larg
number
subject
use
panvir
detect
method
virochip
differenti
among
isol
two
observ
viral
divers
uncov
virochip
analysi
nl
specimen
deriv
studi
particularli
noteworthi
first
divers
distribut
hcov
detect
present
studi
surpris
recent
describ
predomin
hcov
rather
tradit
implic
common
cold
us
adult
popul
instead
see
make
approxim
proport
cold
detect
studi
popul
given
implic
previous
signific
player
outpati
respiratori
tract
ill
among
immunocompet
adult
unit
state
result
unexpect
isol
singl
isol
detect
studi
group
despit
fact
independ
studi
virochip
demonstr
present
readili
detect
c
chiu
urisman
l
greenhow
submit
analysi
requir
determin
whether
pattern
hcov
detect
reflect
increas
suscept
adult
asthma
contract
hcov
arriv
local
outbreak
hcov
type
actual
shift
preval
distinct
hcov
circul
us
adult
popul
second
virochip
detect
remark
unanticip
divers
among
hrv
isol
addit
detect
almost
distinct
hrv
speci
close
relat
known
refer
hrv
serotyp
also
identifi
subgroup
genet
distinct
hrv
signific
fraction
clinic
isol
hrv
although
clinic
signific
hrv
divers
remain
incomplet
understood
detect
high
level
genet
diverg
among
hrv
strain
captur
rel
small
studi
popul
indic
standard
hrv
refer
serotyp
character
almost
year
ago
adequ
describ
divers
current
circul
hrv
believ
hrv
x
strain
anomal
subgroup
hrv
uniqu
studi
popul
similar
proport
diverg
hrv
strain
detect
virochip
analysi
unrel
cohort
pediatr
subject
rti
c
chiu
urisman
l
greenhow
submit
diverg
hrv
also
recent
identifi
studi
pediatr
respiratori
infect
australia
base
noncod
region
sequenc
alon
virtual
ident
isol
hrv
report
independ
analys
hrv
infect
among
european
recent
independ
applic
distinct
panvir
detect
tool
masstag
pcr
analysi
also
document
set
highli
diverg
hrv
circul
us
popul
comparison
sequenc
hrv
x
strain
identifi
suggest
one
hrv
x
strain
hrv
possess
high
sequenc
similar
ident
sequenc
one
diverg
hrv
recent
report
lamson
et
al
howev
sequenc
hrv
x
strain
identifi
possess
nucleotid
sequenc
ident
set
diverg
hrv
identifi
lamson
et
al
identif
distinct
set
genet
diverg
hrv
clinic
isol
indic
set
previous
unrecogn
hrv
current
circul
unit
state
may
quit
larg
deeper
knowledg
extent
current
hrv
divers
inform
futur
studi
role
play
hrv
strain
asthma
exacerb
given
high
proport
event
attribut
infect
agent
sum
present
data
demonstr
virochip
captur
entir
spectrum
known
respiratori
viral
pathogen
singl
test
exhibit
excel
sensit
provid
capac
identifi
asyetundiscov
agent
applic
virochip
prospect
clinic
studi
enabl
us
develop
comprehens
pictur
divers
viral
pathogen
present
infect
critic
miss
piec
puzzl
requir
advanc
understand
differ
viral
pathogen
influenc
cours
spectrum
diseas
